CORCEPT THERAPEUTICS INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Corcept Therapeutics Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Corcept Therapeutics Inc Return On Equity for the quarter ending September 30, 2024 was 24.8 %, a 29.8% increase year-over-year.
  • Corcept Therapeutics Inc annual Return On Equity for 2023 was 22.1 %, a 0.5% decline from 2022.
  • Corcept Therapeutics Inc annual Return On Equity for 2022 was 22.2 %, a 3.73% decline from 2021.
  • Corcept Therapeutics Inc annual Return On Equity for 2021 was 23.1 %, a 2.12% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 24.8 +5.68 +29.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 23.9 +4.21 +21.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 24.4 +4.95 +25.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 22.1 -0.11 -0.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 19.1 -8.42 -30.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 19.7 -5.89 -23.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 19.4 -4.81 -19.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 22.2 -0.86 -3.73% Oct 1, 2022 Dec 31, 2022
Q3 2022 27.5 +7.2 +35.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 25.5 +6.45 +33.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 24.2 +4.12 +20.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 23.1 +0.48 +2.12% Oct 1, 2021 Dec 31, 2021
Q3 2021 20.3 -5.08 -20% Jul 1, 2021 Sep 30, 2021
Q2 2021 19.1 -10 -34.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 20.1 -9.89 -33% Jan 1, 2021 Mar 31, 2021
Q4 2020 22.6 -6.62 -22.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 25.4 -3.7 -12.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 29.1 +1.14 +4.08% Apr 1, 2020 Jun 30, 2020
Q1 2020 30 +1.36 +4.75% Jan 1, 2020 Mar 31, 2020
Q4 2019 29.2 -1.12 -3.69% Oct 1, 2019 Dec 31, 2019
Q3 2019 29.1 -37.7 -56.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 28 -52.3 -65.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 28.6 -73.2 -71.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 30.3 -101 -76.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 66.8 +8.59 +14.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 80.3 +28.9 +56.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 102 +67.9 +200% Jan 1, 2018 Mar 31, 2018
Q4 2017 131 +168 Oct 1, 2017 Dec 31, 2017
Q3 2017 58.2 +119 Jul 1, 2017 Sep 30, 2017
Q2 2017 51.4 +142 Apr 1, 2017 Jun 30, 2017
Q1 2017 33.9 +163 Jan 1, 2017 Mar 31, 2017
Q4 2016 -36.6 +10.8 +22.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -60.6 +79.4 +56.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -90.8 +292 +76.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -129 +827 +86.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -47.4 +1.5K +96.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -140 +335 +70.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -383 -114 -42.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -956 -768 -407% Jan 1, 2015 Mar 31, 2015
Q4 2014 -1.55K -1.42K -1103% Oct 1, 2014 Dec 31, 2014
Q3 2014 -475 -375 -375% Jul 1, 2014 Sep 30, 2014
Q2 2014 -269 -192 -249% Apr 1, 2014 Jun 30, 2014
Q1 2014 -189 -117 -162% Jan 1, 2014 Mar 31, 2014
Q4 2013 -129 -54.5 -73.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -100 -17.5 -21.2% Jul 1, 2013 Sep 30, 2013
Q2 2013 -77.2 +15.8 +16.9% Apr 1, 2013 Jun 30, 2013
Q1 2013 -72 +15.1 +17.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -74 Oct 1, 2012 Dec 31, 2012
Q3 2012 -82.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 -93 Apr 1, 2012 Jun 30, 2012
Q1 2012 -87.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.